Zobrazeno 1 - 10
of 518
pro vyhledávání: '"Robert A, Anders"'
Autor:
Ke Xu, Qingfeng Zhu, Suzanne L Topalian, Robert A Anders, Janis M Taube, Mark Yarchoan, Keziban Ünsal-Kaçmaz, Logan L Engle, Tracee L McMiller, Sepideh Besharati, Junghwa Lee, Feriyl Bhaijee, Alan E Berger
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 11 (2024)
Background Gastric carcinomas (GC) are aggressive malignancies, and only ~15% of patients respond to anti-programmed cell death (ligand) 1 (PD-(L)1) monotherapy. However, Epstein-Barr virus (EBV)-associated GCs (~5–10% of GCs) often harbor PD-L1 an
Externí odkaz:
https://doaj.org/article/ae75b3e80d294d0a8c175faf2abac4ef
Autor:
Shuming Chen, Tracee L. McMiller, Abha Soni, Farah Succaria, John-William Sidhom, Laura C. Cappelli, Livia A. Casciola-Rosen, Isaac R. Morales, Preethi Sankaran, Alan E. Berger, Julie Stein Deutsch, Qingfeng C. Zhu, Robert A. Anders, Jody E. Hooper, Drew M. Pardoll, Evan J. Lipson, Janis M. Taube, Suzanne L. Topalian
Publikováno v:
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-12 (2024)
Abstract Background Tumor regression following immune checkpoint blockade (ICB) is often associated with immune-related adverse events (irAEs), marked by inflammation in non-cancerous tissues. This study was undertaken to investigate the functional r
Externí odkaz:
https://doaj.org/article/44edc95deb6444eabbd3e50a4991237d
Autor:
Shuming Zhang, Long Yuan, Ludmila Danilova, Guanglan Mo, Qingfeng Zhu, Atul Deshpande, Alexander T. F. Bell, Jennifer Elisseeff, Aleksander S. Popel, Robert A. Anders, Elizabeth M. Jaffee, Mark Yarchoan, Elana J. Fertig, Luciane T. Kagohara
Publikováno v:
Genome Medicine, Vol 15, Iss 1, Pp 1-14 (2023)
Abstract Background Novel immunotherapy combination therapies have improved outcomes for patients with hepatocellular carcinoma (HCC), but responses are limited to a subset of patients. Little is known about the inter- and intra-tumor heterogeneity i
Externí odkaz:
https://doaj.org/article/098a7d924d184c9b829632f226e3bd36
Autor:
Keith M Kerr, Elizabeth Thompson, Mariano Provencio, Patrick M Forde, Jaclyn Neely, Ashley Cimino-Mathews, Ludmila Danilova, Daphne Wang, Robert A Anders, Tricia R Cottrell, Nicolas Girard, Janis Taube, Peter Illei, Junliang Cai, Joel Sunshine, Julie Stein Deutsch, Jonathan Spicer, Edward Gabrielson, Jaroslaw Jedrych, Mia Tran, Judy Bushong, Vipul Devas, David Balli, Alex S Baras
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 2 (2023)
Externí odkaz:
https://doaj.org/article/b726db52c75b450c81413c801ce2dbf2
Autor:
Tao Xia, Keyu Li, Nan Niu, Yingkuan Shao, Ding Ding, Dwayne L. Thomas, Hao Jing, Kenji Fujiwara, Haijie Hu, Arsen Osipov, Chunhui Yuan, Christopher L. Wolfgang, Elizabeth D. Thompson, Robert A. Anders, Jin He, Yiping Mou, Adrian G. Murphy, Lei Zheng
Publikováno v:
Journal of Hematology & Oncology, Vol 15, Iss 1, Pp 1-20 (2022)
Abstract Background Immunotherapy has demonstrated a limited clinical efficacy in approximately 5% of cholangiocarcinoma. The main challenges for an effective immunotherapy response in cholangiocarcinoma arise from the tumor microenvironment, which i
Externí odkaz:
https://doaj.org/article/0811bea100fd47df96bb43572ac97480
Autor:
Daniel Li, MD, MA, Angela Y. Jia, MD, PhD, Jane Zorzi, BS, Paige Griffith, MSN, AG-ACNP, BSN, Amy K. Kim, MD, Doan Dao, MD, Robert A. Anders, MD, PhD, Christos Georgiades, MD, PhD, Robert P. Liddell, MD, Kelvin Hong, MD, Nilofer S. Azad, MD, Won Jin Ho, MD, Marina Baretti, MD, Eric Christenson, MD, Azarakhsh Baghdadi, MD, MAS, Ihab R. Kamel, MD, PhD, Jeffrey Meyer, MD, Elie Ghabi, MD, Richard A. Burkhart, MD, Kelly Lafaro, MD, MPH, Jin He, MD, Chris Shubert, MD, Mark Yarchoan, MD
Publikováno v:
Annals of Surgery Open, Vol 3, Iss 4, p e207 (2022)
Objectives:. To compare liver cancer resectability rates before and during the COVID-19 pandemic. Background:. Liver cancers usually present with nonspecific symptoms or are diagnosed through screening programs for at-risk patients, and early detecti
Externí odkaz:
https://doaj.org/article/7e5acd49afd340669a8e3f54361f1158
Autor:
Teris Cheung, Calvin Pak Wing Cheng, Tommy Kwan Hin Fong, Nigussie Tadesse Sharew, Robert L. Anders, Yu Tao Xiang, Simon Ching Lam, SR Nursing Working Group, Ting Ho, Hau Ngai Ling, Calix Ka Yuen Chong, Kelvin Fong Kin Law, Tsun Wai Lee, Wing Hin Lee, Ho Long Yiu
Publikováno v:
Frontiers in Public Health, Vol 10 (2022)
BackgroundAny infectious disease outbreak may lead to a negative detrimental psychological impact on individuals and the community at large, however; there was no systematic review nor meta-analysis that examined the relationship between the psycholo
Externí odkaz:
https://doaj.org/article/b240c98fb2e94c5e855f33fc95a6b83f
Autor:
Annemarie Boleij, Payam Fathi, William Dalton, Ben Park, Xinqun Wu, David Huso, Jawara Allen, Sepideh Besharati, Robert A. Anders, Franck Housseau, Amanda E. Mackenzie, Laura Jenkins, Graeme. Milligan, Shaoguang Wu, Cynthia L. Sears
Publikováno v:
Communications Biology, Vol 4, Iss 1, Pp 1-14 (2021)
Boleij et al. show that G protein-coupled receptor 35 (GPR35) regulates the responses to enterotoxigenic Bacteroides fragilis (ETBF) in colonic epithelial cells. They find that GPR35-deficiency nearly protected mice from ETBF-induced death, suggestin
Externí odkaz:
https://doaj.org/article/2986eba9551643dc8608d3a4c5b5b496
Autor:
Robert L Anders, Wipada Kunaviktikul
Publikováno v:
Journal of Problem-Based Learning, Vol 8, Iss 1, Pp 35-40 (2021)
Aims and Objectives This discursive paper aims to discuss the potential creation of a bridging BNS program in selected Southeast Asian countries to increase the number of nurse educators for the goal of having local educators to increase the number o
Externí odkaz:
https://doaj.org/article/235bd51d0cdf430da14215ab3d113961
Autor:
Mark Yarchoan, Chiung‐Yu Huang, Qingfeng Zhu, Anna K. Ferguson, Jennifer N. Durham, Robert A. Anders, Elizabeth D. Thompson, Noah S. Rozich, Dwayne L. Thomas II, Julie M. Nauroth, Christina Rodriguez, Arsen Osipov, Ana De Jesus‐Acosta, Dung T. Le, Adrian G. Murphy, Daniel Laheru, Ross C. Donehower, Elizabeth M. Jaffee, Lei Zheng, Nilofer S. Azad
Publikováno v:
Cancer Medicine, Vol 9, Iss 4, Pp 1485-1494 (2020)
Abstract Background Mismatch repair proficient (MMRp) colorectal cancer (CRC) has been refractory to single‐agent programmed cell death protein 1 (PD1) inhibitor therapy. Colon GVAX is an allogeneic, whole‐cell, granulocyte‐macrophage colony‐
Externí odkaz:
https://doaj.org/article/d4ba8200190f4f8999ae7ef37f32141a